Verrica Pharmaceuticals Stock Analysis

Verrica Stock Analysis Notes

About 40.0% of the company outstanding shares are owned by insiders. The company has Price/Earnings To Growth (PEG) ratio of 0.03. Verrica Pharmaceuticals recorded a loss per share of 1.48. The entity had not issued any dividends in recent years. Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. Verrica Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in West Chester, Pennsylvania. Verrica Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 38 people. For more information please call Ted White at 484 453 3300 or visit https://www.verrica.com.

Verrica Pharmaceuticals Investment Alerts

Verrica Pharmaceuticals Upcoming and Recent Events

Verrica Largest EPS Surprises

View All Earnings Estimates

Verrica Pharmaceuticals Thematic Classifications

Verrica Stock Institutional Investors

Note, although Verrica Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Verrica Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 290.58 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Verrica Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Verrica Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Verrica Profitablity

Management Efficiency

Verrica Pharmaceuticals has return on total asset (ROA) of (0.6256) % which means that it has lost $0.6256 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.2408) %, meaning that it created substantial loss on money invested by shareholders. Verrica Pharmaceuticals' management efficiency ratios could be used to measure how well Verrica Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. As of April 25, 2024, Return On Tangible Assets is expected to decline to -0.86. In addition to that, Return On Capital Employed is expected to decline to -1.03. At present, Verrica Pharmaceuticals' Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Fixed Asset Turnover is expected to grow to 1.87, whereas Total Assets are forecasted to decline to about 62 M.

Technical Drivers

As of the 25th of April, Verrica Pharmaceuticals has the Coefficient Of Variation of 1267.82, semi deviation of 3.94, and Risk Adjusted Performance of 0.0575. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Verrica Pharmaceuticals, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to break down nineteen technical drivers for Verrica Pharmaceuticals, which can be compared to its competition. Please validate Verrica Pharmaceuticals value at risk, as well as the relationship between the semi variance and kurtosis to decide if Verrica Pharmaceuticals is priced more or less accurately, providing market reflects its prevalent price of 6.79 per share. Given that Verrica Pharmaceuticals has jensen alpha of 0.0871, we advise you to double-check Verrica Pharmaceuticals's current market performance to make sure the company can sustain itself at a future point.

Verrica Pharmaceuticals Price Movement Analysis

Verrica Pharmaceuticals Insider Trading Activities

Verrica Pharmaceuticals Predictive Daily Indicators

Verrica Pharmaceuticals Corporate Filings

Verrica Pharmaceuticals Forecast Models

Verrica Pharmaceuticals' time-series forecasting models are one of many Verrica Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Verrica Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Verrica Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Verrica shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Verrica Pharmaceuticals. By using and applying Verrica Stock analysis, traders can create a robust methodology for identifying Verrica entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Verrica analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Verrica analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Verrica Pharmaceuticals stock analysis indicators help investors evaluate how Verrica Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Verrica Pharmaceuticals shares will generate the highest return on investment. By understating and applying Verrica Pharmaceuticals stock analysis, traders can identify Verrica Pharmaceuticals position entry and exit signals to maximize returns.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Verrica Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. For information on how to trade Verrica Stock refer to our How to Trade Verrica Stock guide.Note that the Verrica Pharmaceuticals information on this page should be used as a complementary analysis to other Verrica Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

When running Verrica Pharmaceuticals' price analysis, check to measure Verrica Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Verrica Pharmaceuticals is operating at the current time. Most of Verrica Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Verrica Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Verrica Pharmaceuticals' price. Additionally, you may evaluate how the addition of Verrica Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.

Is Verrica Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Verrica Pharmaceuticals. If investors know Verrica will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Verrica Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Verrica Pharmaceuticals is measured differently than its book value, which is the value of Verrica that is recorded on the company's balance sheet. Investors also form their own opinion of Verrica Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Verrica Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Verrica Pharmaceuticals' market value can be influenced by many factors that don't directly affect Verrica Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Verrica Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Verrica Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Verrica Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.